ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Jennifer R Shingleton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.